[4P] Genomic Medicine and Gene Therapy

[4P-444] Nasal vaccination against tauopathy using Sendai virus vector

〇Keiko Imamura^1,2,3, Hiroki Takeuchi¹, Naruhiko Sahara⁵, Hideo Hara⁶, Takeshi Tabira⁷, Tetsuya Suhara⁵, Ryosuke Takahashi⁴, Makoto Higuchi⁵, Haruhisa Inoue^1,2,3 (1.Center for iPS Cell Research and Application (CiRA), Kyoto University, 2. iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), 3.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), 4.Department of Neurology, Graduate School of Medicine, Kyoto University, 5.Department of Functional Brain Imaging, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology, 6.Department of Internal Medicine, Saga University Faculty of Medicine, 7.Department of Diagnosis, Prevention and Treatment of Dementia, Faculty of Medicine, Juntendo University)

Keywords:tau, vaccine